2001年1月~2006年1月,我们应用参芪扶正注射液配合化学介入治疗原发性晚期肝癌的患者19例,观察其对介入化学治疗不良反应及机体免疫力的影响,并与单用化学介入治疗的16例作对照,现报告如下:1临床资料35例原发性晚期肝癌的患者均按“中国常见恶性肿瘤诊治规范-原发性肝癌”标准, From January 2001 to January 2006, we used Shenqi Fuzheng injection combined with chemical intervention in the treatment of 19 patients with primary advanced liver cancer, and observed the impact of chemotherapy on adverse reactions and body immunity, and with the single The chemical interventional treatment of 16 cases as a control, are as follows: 1 Clinical data 35 cases of patients with primary liver cancer in accordance with the “common Chinese diagnosis and treatment of malignant tumors - primary liver cancer” standard,